Literature DB >> 8559533

Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy.

B Ramsay1, S R Sooranna, M R Johnson.   

Abstract

OBJECTIVE: To study the changes in nitric oxide synthase activities in human myometrium and trophoblast throughout pregnancy and around delivery.
METHODS: Samples of villous trophoblast were collected from women undergoing elective cesarean delivery at term (n = 12) or voluntary termination of pregnancy in the first (n = 27) or second (n = 11) trimesters of pregnancy. Myometrial samples were obtained from nonpregnant women undergoing hysterectomy (n = 5) and pregnant women both before (n = 7) and after (n = 7) the onset of spontaneous labor at term. Nitric oxide synthase activity was quantified for homogenized samples using the L-citrulline assay in the presence and absence of calcium.
RESULTS: The highest levels of nitric oxide synthase activity were found in first-trimester villi (range 2-29 nmol L-citrulline/minute/g protein), with a significant fall in activity in the third trimester (range 2-10 nmol L-citrulline/minute/g protein; P < .001 for both calcium-dependent and calcium-independent activity). Myometrial activities were relatively low compared with those in the trophoblast (0-2 nmol L-citrulline/minute/g protein), with no significant differences in calcium-dependent activities between subgroups. Myometrial calcium-independent activities were lower in pregnant than in nonpregnant women (P = .007), with those in labor having levels higher than those not in labor (P = .048).
CONCLUSION: Levels of nitric oxide synthase activity are relatively high in villous trophoblast, particularly during the first trimester. Although the contribution to total nitric oxide production in the uterus by myometrial nitric oxide synthase appears to be relatively small, nitric oxide produced by the trophoblast may play a role in maintaining uterine quiescence by a paracrine effect. Further work is needed to test this hypothesis and explore other possible roles for trophoblast-derived nitric oxide in early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8559533     DOI: 10.1016/0029-7844(95)00391-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

Review 1.  The retained placenta.

Authors:  A D Weeks
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

Review 2.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

3.  A decline in myometrial nitric oxide synthase expression is associated with labor and delivery.

Authors:  R K Bansal; P C Goldsmith; Y He; C J Zaloudek; J L Ecker; R K Riemer
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Expression of nitric oxide synthase isoforms in pregnant human myometrium.

Authors:  S R Bartlett; P R Bennett; J S Campa; W J Dennes; D M Slater; G E Mann; L Poston; R Poston
Journal:  J Physiol       Date:  1999-12-15       Impact factor: 5.182

Review 5.  Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Authors:  Maki Kashiwagi; Roland Zimmermann; Ernst Beinder
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

6.  Characterization of the myometrial transcriptome in women with an arrest of dilatation during labor.

Authors:  Piya Chaemsaithong; Ichchha Madan; Roberto Romero; Nandor Gabor Than; Adi L Tarca; Sorin Draghici; Gaurav Bhatti; Lami Yeo; Moshe Mazor; Chong Jai Kim; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Perinat Med       Date:  2013-11       Impact factor: 1.901

7.  Effect of Transdermal Nitroglycerine on Doppler Velocity Waveforms of the Uterine, Umbilical and Fetal Middle Cerebral Arteries in Patients with Chronic Placental Insufficiency: A Prospective RCT.

Authors:  Suruchi Gupta; Meenakshi Chauhan; Jyotsna Sen; Smiti Nanda
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.

Authors:  Marzieh Vahid Dastjerdi; Sayedehafagh Hosseini; Leila Bayani
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

9.  Important differences in nitric oxide synthase activity and predominant isoform in reproductive tissues from human and rat.

Authors:  S Batra; C Iosif; J Al-Hijji; I Larsson
Journal:  Reprod Biol Endocrinol       Date:  2003-02-06       Impact factor: 5.211

10.  Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium.

Authors:  J Al-Hijji; Ellika Andolf; Ricardo Laurini; Satish Batra
Journal:  Reprod Biol Endocrinol       Date:  2003-06-28       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.